re: Ann: VIR201 HIV Vaccine Phase IIa Trial R... well that could have gone better, and a cap raising to come, yippee.
RGT Is the ASX OK? Argent Biopharma plummets as it leaves the bourse one day after Marley spoon; low liquidity blamed